oritavancin
Selected indexed studies
- Oritavancin. (, 2006) [PMID:29999750]
- Oritavancin: an update. (Future Microbiol, 2018) [PMID:29799267]
- Oritavancin: A Novel Lipoglycopeptide. (Consult Pharm, 2016) [PMID:26842686]
_Worker-drafted node — pending editorial review._
Connections
oritavancin is a side effect of
Sources
- Oritavancin. (2006) pubmed
- Oritavancin: an update. (2018) pubmed
- Oritavancin: A Novel Lipoglycopeptide. (2016) pubmed
- Oritavancin: A Long-Half-Life Lipoglycopeptide. (2015) pubmed
- Antibiotic penetration into bone and joints: An updated review. (2019) pubmed
- Oritavancin for acute bacterial skin and skin structure infections. (2015) pubmed
- Oritavancin: an investigational lipoglycopeptide antibiotic. (2013) pubmed
- Oritavancin--an investigational glycopeptide antibiotic. (2006) pubmed
- Oritavancin: first global approval. (2014) pubmed
- Real-World Use of Oritavancin for the Treatment of Osteomyelitis. (2020) pubmed